A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2002
11/28/2002	DE10125763A1 New use of indirubin derivatives as VEGF inhibitors useful for preparing medicaments useful for e.g. treating cancer, autoimmune diseases, cardiovascular diseases or viral infections
11/28/2002	DE10123586A1 New 3,5-diamino-1,2,4-triazole derivatives, are cyclin dependent kinase inhibitors useful for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections
11/28/2002	DE10123505A1 New immunoconjugate comprising egg yolk immunoglobulin Y, useful for treating e.g. inflammation or infection, is derived from specific pathogen-free hens
11/28/2002	DE10123041A1 New single-chain human antibody fragment, useful for treating or diagnosing hepatitis C virus infection, has affinity for an essential viral protein
11/28/2002	DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002	CA2826505A1 Antiviral nucleosides
11/28/2002	CA2755964A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	CA2450677A1 A novel intein and uses thereof
11/28/2002	CA2449442A1 Combination medicament for treatment of neoplastic diseases
11/28/2002	CA2448670A1 Carbapenem compound
11/28/2002	CA2448174A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002	CA2448092A1 Internalisation of virus into cells
11/28/2002	CA2448045A1 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002	CA2448022A1 Compositions for protein delivery via the pulmonary route
11/28/2002	CA2448014A1 Tsg101 as inhibitor of hiv production
11/28/2002	CA2447676A1 New benzylaminopyrimidines
11/28/2002	CA2447675A1 Novel pyridylmethylaminopyrimidines
11/28/2002	CA2447616A1 Vaccine composition
11/28/2002	CA2447600A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/28/2002	CA2447338A1 Receptors and membrane-associated proteins
11/28/2002	CA2447274A1 Heterologous protection induced by immunization with invaplex vaccine
11/28/2002	CA2447227A1 Process for the preparation of imipenem
11/28/2002	CA2447180A1 Herbal compositions for the treatment of mucosal lesions
11/28/2002	CA2447170A1 Emulsion and dispersion formulations and method
11/28/2002	CA2447161A1 Conjugates and compositions for cellular delivery
11/28/2002	CA2447023A1 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	CA2447020A1 The use of 4-aminopyridine derivatives for the treatment of mglur5 receptor mediated diseases
11/28/2002	CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002	CA2446620A1 Antiviral nucleosides
11/28/2002	CA2446398A1 Nucleic acid and protein sequences of bovine epidermal growth factor
11/28/2002	CA2446155A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	CA2445631A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002	CA2444487A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists
11/28/2002	CA2443287A1 Methods for regulating bacteria
11/28/2002	CA2443258A1 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
11/28/2002	CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	CA2440368A1 Staphylococcus aureus proteins and nucleic acids
11/28/2002	CA2427619A1 Pharmaceutically active isoindoline derivatives
11/28/2002	CA2410763A1 Medicinal compositions containing propenone derivatives
11/27/2002	EP1260591A1 High-efficiency assay for protein mannosyl transferases
11/27/2002	EP1260590A1 Method of screening substance specifically inhibiting non-mevalonate pathway
11/27/2002	EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002	EP1260227A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/27/2002	EP1259923A2 Anti-infective agents useful against mulitidrug-resistant strains of bacteria
11/27/2002	EP1259639A2 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
11/27/2002	EP1259629A2 Recombinant influenza a viruses
11/27/2002	EP1259621A2 Lipid metabolism enzymes
11/27/2002	EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002	EP1259611A2 G-protein coupled receptors
11/27/2002	EP1259595A2 Integrin antagonists
11/27/2002	EP1259547A2 High potency recombinant antibodies and method for producing them
11/27/2002	EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002	EP1259536A2 Methods of peptide preparation
11/27/2002	EP1259535A1 Cyclic hexapeptide derivatives
11/27/2002	EP1259527A1 35 human secreted proteins
11/27/2002	EP1259523A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/27/2002	EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
11/27/2002	EP1259497A1 Novel quinoline ligands and metal complexes for diagnosis and therapy
11/27/2002	EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002	EP1259482A2 Sulfur containing compounds
11/27/2002	EP1259262A1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/27/2002	EP1259261A1 Pharmaceutical compositions comprising terbinafine
11/27/2002	EP1259259A2 Mucosal adjuvant formulation
11/27/2002	EP1259258A1 Gm-negative ehv-mutants
11/27/2002	EP1259257A2 In ovo protection against infectious bronchitis
11/27/2002	EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002	EP1192152B1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
11/27/2002	EP1180164A4 Methods using of fab i and compounds modulating fab i activity
11/27/2002	EP1059931B1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
11/27/2002	EP1017672B1 New npy antagonists
11/27/2002	EP0998480B1 Nucleotide analog composition and synthesis method
11/27/2002	EP0996430B1 Nucleotide analog compositions
11/27/2002	EP0934331B1 Mirror-symmetrical selection and evolution of nucleic acids
11/27/2002	EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002	EP0708648B1 Inhibition of nitric oxide production by retinoic acid
11/27/2002	EP0675961B1 Treatment of tumorigenic disease with a modified HSV
11/27/2002	EP0608261B1 Immunoreactive hepatitis c virus polypeptide compositions
11/27/2002	EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002	CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002	CN1382206A Color safe laundry methods employing zwitterionic formulation components
11/27/2002	CN1382158A Multiple cytokine-antibody complexes
11/27/2002	CN1382157A Therapeutic compounds comprised of anti-FC receptor binding agents
11/27/2002	CN1382153A 重组亚单位疫苗 Recombinant subunit vaccine
11/27/2002	CN1382152A Novel A-500359 derivatives
11/27/2002	CN1382150A Hydromycin derivatives
11/27/2002	CN1382149A Hygromycin A prodrugs
11/27/2002	CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002	CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002	CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002	CN1382139A Method and intermediate for preparing is-a-oxazole formylamine and its analogue
11/27/2002	CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002	CN1382061A Pharmaceutical compositions for oral and topical administration
11/27/2002	CN1382059A Method and compositions for prevneting or reducing HIV infection
11/27/2002	CN1382044A Use of cell factor inhibiting anti-inflammatory agent in rhinovirus infection
11/27/2002	CN1382040A Therapeutic method
11/27/2002	CN1381582A Targetting high-expression recombinant adenovirus of human granulocyte-macrophage colony stimulating factor and its preparing process and usage
11/27/2002	CN1381465A Gene configuration, preparing process and usage of antibacterial peptide
11/27/2002	CN1381269A Plaster for treating inflammations and sores
11/27/2002	CN1381268A Liquid composite medicine for killing varient bacteria or viruses

1 ... 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 ... 1798